SCHEMBL4915223

SCHEMBL4915223

CC(C)(C)C[PH](=O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
ALDH1A1 P00352 2/20 0.42
RIPK1 Q13546 2/20 0.40
AOC3 Q16853 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
USP2 O75604 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
PYCR1 P32322 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4919937 0.73 KMT2A (0.39) TSHRALDH1A1MEN1HTTKMT2A
SCHEMBL29974414 0.70 ALDH1A1 (0.44) TSHRALDH1A1AOC3MEN1HTT
SCHEMBL29377889 0.66 TSHR (0.50) TSHRALDH1A1RIPK1AOC3MEN1
SCHEMBL9123668 0.66 SLC6A2 (0.41) TSHRALDH1A1RIPK1MEN1HTT
SCHEMBL4924726 0.66 GAA (0.34) TSHRALDH1A1RIPK1MEN1KMT2A
SCHEMBL13673152 0.66 TSHR (0.50) TSHRALDH1A1RIPK1AOC3MEN1
SCHEMBL16051949 0.66 ALDH1A1 (0.50) TSHRALDH1A1RIPK1AOC3MEN1
SCHEMBL3064626 0.66 AOC3 (0.46) TSHRALDH1A1AOC3HTTNPC1
SCHEMBL5962473 0.65 TSHR (0.54) TSHRALDH1A1RIPK1AOC3MEN1
SCHEMBL74267 0.65 TSHR (0.54) TSHRALDH1A1RIPK1AOC3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 US disclosed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 US disclosed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP disclosed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255391-A1 Chiral Phosphorus Compounds PHOSPHO1, PNKP, PTMS TSHR 2680/4885ALDH1A1 612/4885RIPK1 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.